Doctors recommend avoiding NSAIDs after a flu vaccination because these can dampen the immune response by slashing the ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Actor Dave Coulier, known for playing Uncle Joey on the TV series Full House, announced he has stage 3 non-Hodgkin's lymphoma ...

When Beata Halassy learned in summer 2020 that her breast cancer had come back, she made a bold decision. As a virologist at ...

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...

Beata Halasi, a virologist at the University of Zagreb, attempted a bold and unconventional approach by using virus-based ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good morning ladies and gentlemen and welcome to PDS Biotech’s Third Quarter 2024 Results and Clinical Strategy Update Conference Call. All ...

RESEARCHERS from SINTEF have developed a “simpler” low-cost carbon capture and storage (CCS) system for sequestering ...

Q3 2024 Earnings Call Transcript November 14, 2024 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.36. Operator: Good morning, and ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotech ...

Earlier this year, a surprising story emerged about RFK Jr. — the newly named nominee for secretary of the Department of ...